Items by By NATASHA SINGER
NYT > Business
-
In Chief Executives’ Pay, a Rich Game of Thrones
Posted: April 8th, 2012, 10:13am EDT by By NATASHA SINGER
Tags: [edit]
Although the growth in C.E.O. compensation slowed last year, the pay numbers are still eye-popping.
NYT > Home Page
-
In Chief Executives’ Pay, a Rich Game of Thrones
Posted: April 8th, 2012, 10:13am EDT by By NATASHA SINGER
Tags: [edit]
Although the growth in C.E.O. compensation slowed last year, the pay numbers are still eye-popping.
NYT > Business
-
Nuance Communications Wants a World of Voice Recognition
Posted: April 1st, 2012, 1:08am EDT by By NATASHA SINGER
Tags: [edit]
Nuance Communications, the leading company in voice technology, is expanding its efforts to make more kinds of machines responsive to our spoken commands.
NYT > Health
-
Calls Grow for Leader of Susan G. Komen for the Cure to Resign
Posted: March 22nd, 2012, 4:02pm EDT by By NATASHA SINGER
Tags: [edit]
The resignation of the chief executive of the group’s New York affiliate added to pressure on Nancy G. Brinker to step down after a controversy over financing for Planned Parenthood.
NYT > Business
-
Slipstream: Minds at Work Helps Managers Find, and Fix, Their Flaws
Posted: March 17th, 2012, 10:30pm EDT by By NATASHA SINGER
Tags: [edit]
A new program guides executives through exercises that can stop them from undermining their own goals.
-
I.B.M. Takes ‘Smarter Cities’ Concept to Rio de Janeiro
Posted: March 3rd, 2012, 4:58pm EST by By NATASHA SINGER
Tags: [edit]
I.B.M. has designed a new operations center for the city of Rio de Janeiro, coordinating all kinds of functions under one roof. The company hopes the project will lead to a huge worldwide business.
-
Slipstream: Employers and Brands Use Gaming to Gauge Engagement
Posted: February 4th, 2012, 8:20pm EST by By NATASHA SINGER
Tags: [edit]
More companies are turning to gamification — offering games that let their customers win points for certain activities — as a way to build both loyalty and a trove of data.
-
Slipstream: The Human Anatomy, Animated With 3-D Technology
Posted: January 8th, 2012, 1:15am EST by By NATASHA SINGER
Tags: [edit]
A 3-D virtual body, now used by medical students in anatomy studies, represents an unusual collaboration between industry and academia.
-
Slipstream: The Human Anatomy, Animated With 3-D Technology
Posted: January 8th, 2012, 1:15am EST by By NATASHA SINGER
Tags: [edit]
A 3-D virtual body, now used by medical students in anatomy studies, represents an unusual collaboration between industry and academia.
NYT > Health
-
Slipstream: The Human Anatomy, Animated With 3-D Technology
Posted: January 8th, 2012, 1:15am EST by By NATASHA SINGER
Tags: [edit]
A 3-D virtual body, now used by medical students in anatomy studies, represents an unusual collaboration between industry and academia.
-
Slipstream: The Human Anatomy, Animated With 3-D Technology
Posted: January 8th, 2012, 1:15am EST by By NATASHA SINGER
Tags: [edit]
A 3-D virtual body, now used by medical students in anatomy studies, represents an unusual collaboration between industry and academia.
NYT > Business
-
New Year’s Resolutions, Recycled, Are a Boon for Business
Posted: January 1st, 2012, 7:45am EST by By NATASHA SINGER
Tags: [edit]
The self-improvement industry thrives on New Year’s resolutions gone awry. After all, if you don’t lose those pounds or stop smoking this year, you’ll probably try again in 2013.
NYT > Health
-
New Year’s Resolutions, Recycled, Are a Boon for Business
Posted: January 1st, 2012, 7:45am EST by By NATASHA SINGER
Tags: [edit]
The self-improvement industry thrives on New Year’s resolutions gone awry. After all, if you don’t lose those pounds or stop smoking this year, you’ll probably try again in 2013.
NYT > Business
-
Slipstream: Bill Would Let Video Consumers Disclose All Their Choices
Posted: December 10th, 2011, 8:32pm EST by By NATASHA SINGER
Tags: [edit]
A bill passed by the House would allow consumers to give one-time blanket consent for a company to share their video viewing habits.
NYT > Home Page
-
Slipstream: Bill Would Let Video Consumers Disclose All Their Choices
Posted: December 10th, 2011, 8:32pm EST by By NATASHA SINGER
Tags: [edit]
A bill passed by the House would allow consumers to give one-time blanket consent for a company to share their video viewing habits.
NYT > Business
-
How Freedom Group Became the Gun Industry’s Giant
Posted: November 27th, 2011, 11:47am EST by By NATASHA SINGER
Tags: [edit]
In the last few years, many of the top names in rifles and shotguns have been acquired by a corporate unknown: the Freedom Group.
NYT > Health
-
In the Breast Cancer Fight, the Pinking of America
Posted: October 19th, 2011, 11:00am EDT by By NATASHA SINGER
Tags: [edit]
A marketing powerhouse has arisen in the war on breast cancer — and, like it or not, it is shaping the national conversation about the disease.
-
Drugs Posing as Supplementals May Contain Dangerous Ingredients
Posted: August 29th, 2011, 2:48pm EDT by By NATASHA SINGER
Tags: [edit]
Drugs marketed in the guise of supplements may contain dangerous amphetamines, synthetic steroids, laxatives and other prohibited compounds.
NYT > Business
-
When S’Mores Aren’t Enough: The New Economics of Summer Camp
Posted: July 10th, 2011, 9:51am EDT by By NATASHA SINGER
Tags: [edit]
The economy has made the business of summer camp tougher — so having fun is only part of the equation. Many camps now offer special services to please demanding families.
NYT > Health
-
Foods With Benefits, or So They Say
Posted: May 17th, 2011, 4:51pm EDT by By NATASHA SINGER
Tags: [edit]
Labels proclaiming health benefits of foods almost shout out in the aisles of supermarkets. But shoppers, and regulators, have their hands full trying to sort it all out.
-
Slipstream: Data Privacy, Put to the Test
Posted: April 30th, 2011, 9:43pm EDT by By NATASHA SINGER
Tags: [edit]
A case before the Supreme Court is ostensibly about medical privacy, but it taps into a much broader debate about consumer protection and informed consent.
-
A Fight Over How Drugs Are Pitched
Posted: April 26th, 2011, 2:26pm EDT by By NATASHA SINGER
Tags: [edit]
Marketing to doctors using prescription records bearing their names is an increasingly contentious practice, with three states enacting laws to limit the uses of the records for marketing.
-
Prescriptions: J. & J. Unit Recalls Epilepsy Drug
Posted: April 14th, 2011, 12:08pm EDT by By NATASHA SINGER
Tags: [edit]
The company received complaints of a moldy odor.
-
Prescriptions: The Case of the Missing Pepcid Tablets
Posted: March 8th, 2011, 1:50pm EST by By NATASHA SINGER
Tags: [edit]
Once again, a product disappears rather mysteriously from the shelves, without much explanation from its manufacturer.
NYT > Business
-
In a Graying Population, Business Opportunity
Posted: February 7th, 2011, 4:01pm EST by By NATASHA SINGER
Tags: [edit]
Researchers are helping companies make products geared toward older people yet attractive to younger buyers.
NYT > Health
-
In a Graying Population, Business Opportunity
Posted: February 7th, 2011, 4:01pm EST by By NATASHA SINGER
Tags: [edit]
Researchers are helping companies make products geared toward older people yet attractive to younger buyers.
-
Prescriptions: Product Recalls Weaken J.& J. Sales
Posted: January 25th, 2011, 4:51pm EST by By NATASHA SINGER
Tags: [edit]
The company also said some prescription medicine sales were lower.
NYT > Business
-
Prescriptions: J.&J. Recalls More Products
Posted: January 14th, 2011, 5:44pm EST by By NATASHA SINGER
Tags: [edit]
The company said it was removing 43 million packages of Tylenol, Benadryl, Sudafed and Sinutab and other products.
NYT > Health
-
Prescriptions: J.&J. Recalls More Products
Posted: January 14th, 2011, 5:44pm EST by By NATASHA SINGER
Tags: [edit]
The company said it was removing 43 million packages of Tylenol, Benadryl, Sudafed and Sinutab and other products.
NYT > Business
-
Slipstream: Playing Catch-Up in a Digital Library Race
Posted: January 8th, 2011, 1:13pm EST by By NATASHA SINGER
Tags: [edit]
As Japan and European countries are digitizing collections for national one-stop searching, efforts in the United States have been scattered.
NYT > Health
-
Prescriptions: The Case of the Missing o.b. Tampons
Posted: December 22nd, 2010, 3:46pm EST by By NATASHA SINGER
Tags: [edit]
A popular feminine hygiene product has been noticeably disappearing from store shelves, without a definite explanation.
NYT > Business
-
N. C. Plant Found to Be Maker of Recalled Rolaids
Posted: December 18th, 2010, 1:57am EST by By NATASHA SINGER
Tags: [edit]
In congressman’s letter to the F.D.A., the Best Sweet plant in Mooresville, N.C., is revealed as the maker of millions of Rolaids recalled by Johnson & Johnson.
NYT > Health
-
N. C. Plant Found to Be Maker of Recalled Rolaids
Posted: December 18th, 2010, 1:57am EST by By NATASHA SINGER
Tags: [edit]
In congressman’s letter to the F.D.A., the Best Sweet plant in Mooresville, N.C., is revealed as the maker of millions of Rolaids recalled by Johnson & Johnson.
-
2 in Race to Lead Johnson & Johnson
Posted: December 16th, 2010, 1:06am EST by By NATASHA SINGER
Tags: [edit]
Two longtime executives, Alex Gorsky and Sheri S. McCoy, have been given expanded roles in the troubled health care company.
NYT > Business
-
Slipstream: Technology Outpaces Privacy (Yet Again)
Posted: December 12th, 2010, 3:48am EST by By NATASHA SINGER
Tags: [edit]
The widespread adoption of technology has often left legislators and regulators racing to play catch up. In 1890, it was cameras. Today, cookies.
-
J.&J. Unit Issues Recall of Rolaids
Posted: December 9th, 2010, 9:07pm EST by By NATASHA SINGER
Tags: [edit]
A Johnson & Johnson unit announced a nationwide recall of more than 13 million packages of Rolaids after reports of consumers finding metal and wood particles in the products.
NYT > Home Page
-
J.&J. Unit Issues Recall Of Rolaids
Posted: December 9th, 2010, 8:35pm EST by By NATASHA SINGER
Tags: [edit]
A Johnson & Johnson unit announced a nationwide recall of more than 13 million packages of the soft chewable versions of Rolaids after reports of consumers finding metal and wood particles in the products.
NYT > Health
-
Prescriptions: The Week Ahead in Drug Industry News
Posted: December 6th, 2010, 11:48am EST by By NATASHA SINGER
Tags: [edit]
An F.D.A. panel reviews an experimental anti-obesity drug.
NYT > Business
-
Prescriptions: Merck Appoints a New Chief Executive
Posted: November 30th, 2010, 4:14pm EST by By NATASHA SINGER
Tags: [edit]
Kenneth C. Frazier was named to succeed Richard T. Clark.
NYT > Health
-
Prescriptions: Merck Appoints a New Chief Executive
Posted: November 30th, 2010, 4:14pm EST by By NATASHA SINGER
Tags: [edit]
Kenneth C. Frazier was named to succeed Richard T. Clark.
-
Drug Maker Cited on Quality Issues
Posted: November 27th, 2010, 3:30am EST by By NATASHA SINGER
Tags: [edit]
A new F.D.A. inspection shows that a division of Johnson & Johnson has not corrected its manufacturing problems.
-
Privacy Groups Fault Online Health Sites for Sharing User Data With Marketers
Posted: November 24th, 2010, 1:27am EST by By NATASHA SINGER
Tags: [edit]
A complaint filed with the Federal Trade Commission says that QualityHealth and similar sites offer users medical information, but don’t make it clear that personal data is used for drug marketing.
NYT > Home Page
-
Prescriptions: Cholesterol Pill May Help Kidneys
Posted: November 20th, 2010, 3:50pm EST by By NATASHA SINGER
Tags: [edit]
A new study reports heart benefits for patient with chronic kidney disease who took Vytorin to lower their cholesterol.
NYT > Business
-
Study Suggests a Cholesterol Pill Benefits Patients With Kidney Disease
Posted: November 20th, 2010, 3:13pm EST by By NATASHA SINGER
Tags: [edit]
Patients with chronic kidney disease who took Vytorin, a cholesterol-lowering pill, had one-sixth fewer heart attacks, strokes or operations to unblock their arteries than patients taking a placebo.
NYT > Health
-
Study Suggests a Cholesterol Pill Benefits Patients With Kidney Disease
Posted: November 20th, 2010, 3:13pm EST by By NATASHA SINGER
Tags: [edit]
Patients with chronic kidney disease who took Vytorin, a cholesterol-lowering pill, had one-sixth fewer heart attacks, strokes or operations to unblock their arteries than patients taking a placebo.
-
Prescriptions: Lowering Bad Cholesterol Reduced Heart Problems in Kidney Patients, Study Shows
Posted: November 20th, 2010, 2:27pm EST by By NATASHA SINGER
Tags: [edit]
A new study reports heart benefits for patient with chronic kidney disease who took Vytorin to lower their cholesterol.
NYT > Business
-
Merck Not at Fault in Fosamax Trial, Jurors Say
Posted: November 20th, 2010, 12:30am EST by By NATASHA SINGER
Tags: [edit]
Judith Graves, a Florida woman, had sued the company, claiming that its osteoporosis drug, Fosamax, caused her jawbone to disintegrate.
NYT > Health
-
Prescriptions: What We're Reading: Dr. Author
Posted: November 18th, 2010, 1:56pm EST by By NATASHA SINGER
Tags: [edit]
A bioethicist examines ghostwriting while a cancer expert debunks lung-cancer screening.
NYT > Business
-
Merck Cholesterol Drug Looks Promising
Posted: November 17th, 2010, 5:51pm EST by By NATASHA SINGER
Tags: [edit]
Patients taking the drug anacetrapib had a 39.8 percent reduction in bad cholesterol and a 138.1 percent increase in good cholesterol.
NYT > Health
-
Merck Cholesterol Drug Looks Promising
Posted: November 17th, 2010, 5:51pm EST by By NATASHA SINGER
Tags: [edit]
Patients taking the drug anacetrapib had a 39.8 percent reduction in bad cholesterol and a 138.1 percent increase in good cholesterol.
NYT > Business
-
Prescriptions: Cholesterol Drug Shows Promise
Posted: November 17th, 2010, 10:16am EST by By NATASHA SINGER
Tags: [edit]
An experimental treatment using anacetrapib appeared to reduce bad cholesterol, but larger studies are needed to assess the effects.
NYT > Health
-
Prescriptions: Cholesterol Drug Shows Promise
Posted: November 17th, 2010, 10:16am EST by By NATASHA SINGER
Tags: [edit]
An experimental treatment using anacetrapib appeared to reduce bad cholesterol, but larger studies are needed to assess the effects.
NYT > Business
-
Drug Suits Raise Questions for Doctors, and Juries
Posted: November 11th, 2010, 1:20am EST by By NATASHA SINGER
Tags: [edit]
As recent lawsuits suggest a long-term risk, doctors and drug makers are debating the use of osteoporosis drugs.
NYT > Health
-
Drug Suits Raise Questions for Doctors, and Juries
Posted: November 11th, 2010, 1:20am EST by By NATASHA SINGER
Tags: [edit]
As recent lawsuits suggest a long-term risk, doctors and drug makers are debating the use of osteoporosis drugs.
-
Prescriptions: Recommended Reading: 'Bad Science'
Posted: October 27th, 2010, 2:07pm EDT by By NATASHA SINGER
Tags: [edit]
A new book debunks medical quackery -- and mainstream medicine.
-
Prescriptions: Tylenol Recalls Erode Johnson & Johnson Sales
Posted: October 22nd, 2010, 8:06am EDT by By NATASHA SINGER
Tags: [edit]
A series of product problems lowered third-quarter sales.
NYT > Business
-
Sales Decline, but Earnings Go Up for Johnson & Johnson
Posted: October 19th, 2010, 6:04pm EDT by By NATASHA SINGER
Tags: [edit]
The company, which increased its earnings guidance for the year, blamed lower third-quarter sales on recalls its brand-name medicines.
-
Prescriptions: More Trouble With Tylenol
Posted: October 18th, 2010, 6:48pm EDT by By NATASHA SINGER
Tags: [edit]
J&J's McNeil division announces another recall of Tylenol, this time citing a musty odor.
NYT > Health
-
Prescriptions: More Trouble With Tylenol
Posted: October 18th, 2010, 6:48pm EDT by By NATASHA SINGER
Tags: [edit]
J&J's McNeil division announces another recall of Tylenol, this time citing a musty odor.
NYT > Business
-
Botox Shots Approved for Migraine
Posted: October 16th, 2010, 12:50am EDT by By NATASHA SINGER
Tags: [edit]
Allergan, Botox’s maker, recently agreed to pay $600 million to settle allegations that it had illegally marketed the drug for unapproved uses like headaches for years.
NYT > Health
-
Botox Shots Approved for Migraine
Posted: October 16th, 2010, 12:50am EDT by By NATASHA SINGER
Tags: [edit]
Allergan, Botox’s maker, recently agreed to pay $600 million to settle allegations that it had illegally marketed the drug for unapproved uses like headaches for years.
-
Prescriptions: Botox for Migraines Is Approved
Posted: October 15th, 2010, 9:52pm EDT by By NATASHA SINGER
Tags: [edit]
The Food and Drug Administration’s decision to give Allergan the go-ahead to market Botox for chronic migraines comes after the company paid $600 million to settle illegal marketing allegations.
-
The Botox Special
Posted: October 7th, 2010, 6:07pm EDT by By NATASHA SINGER
Tags: [edit]
Advertising for Botox goes on and on.
-
Agency Acts to Ease Delay of Pills for Elderly
Posted: October 7th, 2010, 2:20am EDT by By NATASHA SINGER
Tags: [edit]
The Drug Enforcement Administration issued a new guideline intended to help some nursing home residents with the delays they face receiving certain painkillers and anti-anxiety medications.
-
The Week Ahead in Health Industry News
Posted: September 20th, 2010, 11:51pm EDT by By NATASHA SINGER
Tags: [edit]
A cardiology advisory panel at the Food and Drug Administration reviews a new heart drug. Insurers must adopt some provisions of the health overhaul law starting Thursday.
NYT > Business
-
Slipstream: Better Health, With a Little Help From Our Friends
Posted: September 19th, 2010, 3:27am EDT by By NATASHA SINGER
Tags: [edit]
Scientists are studying relationships among friends, co-workers and neighbors to learn how they can be used to improve public health.
NYT > Health
-
Slipstream: Better Health, With a Little Help From Our Friends
Posted: September 19th, 2010, 3:27am EDT by By NATASHA SINGER
Tags: [edit]
Scientists are studying relationships among friends, co-workers and neighbors to learn how they can be used to improve public health.
-
Forest, Maker of Celexa, to Pay More Than $313 Million to Settle Marketing Case
Posted: September 16th, 2010, 12:56am EDT by By NATASHA SINGER
Tags: [edit]
The complaint against Forest Pharmaceuticals included a claim that it illegally marketed a drug for use in children.
-
Recommended Weekend Reading
Posted: September 10th, 2010, 2:59pm EDT by By NATASHA SINGER
Tags: [edit]
The New England Journal revisits the mammography wars, while PLoS Medicine examines ghostwritten articles in the scientific literature.
NYT > Business
-
After Fine, Botox Awaits Approval for Migraine
Posted: September 9th, 2010, 1:00am EDT by By NATASHA SINGER
Tags: [edit]
Allergan will pay $600 million for its marketing tactics while the F.D.A. decides on the drug’s use for migraines.
NYT > Health
-
After Fine, Botox Awaits Approval for Migraine
Posted: September 9th, 2010, 1:00am EDT by By NATASHA SINGER
Tags: [edit]
Allergan will pay $600 million for its marketing tactics while the F.D.A. decides on the drug’s use for migraines.
-
Bristol-Myers Squibb to Buy ZymoGenetics
Posted: September 7th, 2010, 6:52pm EDT by By NATASHA SINGER
Tags: [edit]
The deal is about $885 million, Bristol said.
-
The Week Ahead in Health Industry News
Posted: September 7th, 2010, 11:35am EDT by By NATASHA SINGER
Tags: [edit]
This week focuses on news about emergency room visits and the ramifications of the health care law.
NYT > Business
-
Maker of Botox Settles Inquiry
Posted: September 2nd, 2010, 2:00am EDT by By NATASHA SINGER
Tags: [edit]
Allergan agreed to pay $600 million to settle charges that it illegally promoted and sold Botox for unapproved uses.
NYT > Health
-
Maker of Botox Settles Inquiry
Posted: September 2nd, 2010, 2:00am EDT by By NATASHA SINGER
Tags: [edit]
Allergan agreed to pay $600 million to settle charges that it illegally promoted and sold Botox for unapproved uses.
NYT > Home Page
-
Maker of Botox Settles Inquiry
Posted: September 2nd, 2010, 2:00am EDT by By NATASHA SINGER
Tags: [edit]
Allergan agreed to pay $600 million to settle charges that it illegally promoted and sold Botox for unapproved uses.
NYT > Health
-
Maker of Botox Settles Case for $600 Million
Posted: September 1st, 2010, 4:30pm EDT by By NATASHA SINGER
Tags: [edit]
Allergan agreed to settle criminal and civil allegations that it had marketed Botox for uses not approved by the Food and Drug Administration.
NYT > Business
-
New Rivals to Warfarin as Blood Clot Preventer
Posted: September 1st, 2010, 1:19am EDT by By NATASHA SINGER
Tags: [edit]
A Bristol-Myers drug shows promise in treating a heart rhythm disorder, and others combat postsurgical clotting and deep vein thrombosis.
NYT > Health
-
New Rivals to Warfarin as Blood Clot Preventer
Posted: September 1st, 2010, 1:19am EDT by By NATASHA SINGER
Tags: [edit]
A Bristol-Myers drug shows promise in treating a heart rhythm disorder, and others combat postsurgical clotting and deep vein thrombosis.
-
The Race to Replace Warfarin
Posted: August 31st, 2010, 5:43pm EDT by By NATASHA SINGER
Tags: [edit]
Leading drug makes are developing new anticoagulant drugs to prevent stroke and systemic blood clots in people with atrial fibrillation, an irregular heartbeat disorder.
NYT > Business
-
Companies Race to Develop Drugs to Reduce Blood-Clotting Problems
Posted: August 31st, 2010, 1:18am EDT by By NATASHA SINGER
Tags: [edit]
The drugs are aimed at people who have a higher than normal risk for clotting or stroke, like patients undergoing hip replacement surgery or those with an irregular heartbeat.
NYT > Health
-
Companies Race to Develop Drugs to Reduce Blood-Clotting Problems
Posted: August 31st, 2010, 1:18am EDT by By NATASHA SINGER
Tags: [edit]
The drugs are aimed at people who have a higher than normal risk for clotting or stroke, like patients undergoing hip replacement surgery or those with an irregular heartbeat.
NYT > Business
-
Johnson & Johnson Recalls Hip Implants
Posted: August 26th, 2010, 1:38pm EDT by By NATASHA SINGER
Tags: [edit]
It was the latest in a succession of recalls of some of the company’s best-selling products.
NYT > Health
-
Johnson & Johnson Recalls Hip Implants
Posted: August 26th, 2010, 1:38pm EDT by By NATASHA SINGER
Tags: [edit]
It was the latest in a succession of recalls of some of the company’s best-selling products.
NYT > Home Page
-
Johnson & Johnson Recalls Hip Implants
Posted: August 26th, 2010, 1:15pm EDT by By NATASHA SINGER
Tags: [edit]
It was the latest in a succession of recalls of some of the company’s best-selling products.
NYT > Health
-
Poll: Americans Skimp on Medicines
Posted: August 25th, 2010, 8:38am EDT by By NATASHA SINGER
Tags: [edit]
Thirty-nine percent of people polled said they had economized on medical care within the last year, according to a survey released Tuesday by Consumer Reports National Research Center.
NYT > Business
-
Acuvue Contact Lenses Are Recalled in Asia and Europe
Posted: August 24th, 2010, 4:18am EDT by By NATASHA SINGER
Tags: [edit]
The recall of 1-Day Acuvue TruEye does not include soft disposable lenses sold in the United States or other countries under the same brand name.
NYT > Health
-
Acuvue Contact Lenses Are Recalled in Asia and Europe
Posted: August 24th, 2010, 4:18am EDT by By NATASHA SINGER
Tags: [edit]
The recall of 1-Day Acuvue TruEye does not include soft disposable lenses sold in the United States or other countries under the same brand name.
-
Human Eggs for Sale and Other Tales
Posted: August 23rd, 2010, 4:36pm EDT by By NATASHA SINGER
Tags: [edit]
The latest reading on the marketplace for human eggs, quality control problems at Johnson & Johnson, and doctors who own surgical centers.
NYT > Business
-
Slipstream: Fighting Obesity Through Public and Private Policy
Posted: August 21st, 2010, 10:50pm EDT by By NATASHA SINGER
Tags: [edit]
In the fight against obesity, the entire food landscape — from pricing to advertising to availability — may need reshaping.
NYT > Health
-
Slipstream: Fighting Obesity Through Public and Private Policy
Posted: August 21st, 2010, 10:50pm EDT by By NATASHA SINGER
Tags: [edit]
In the fight against obesity, the entire food landscape — from pricing to advertising to availability — may need reshaping.
-
Recommended Weekend Reading
Posted: August 20th, 2010, 12:59pm EDT by By NATASHA SINGER
Tags: [edit]
A new article in Mother Jones examines the ethics of medical research conducted for marketing purposes.
-
Johnson & Johnson to Reorganize Its Quality Controls
Posted: August 19th, 2010, 1:30am EDT by By NATASHA SINGER
Tags: [edit]
After a series of recalls, the company will create a single quality-control framework for its drug, medical device and consumer health care units.
NYT > Business
-
Johnson & Johnson to Reorganize Its Quality Controls
Posted: August 18th, 2010, 9:30pm EDT by By NATASHA SINGER
Tags: [edit]
After a series of recalls, the company will create a single quality-control framework for its drug, medical device and consumer health care units.
NYT > Health
-
This Week's Health Industry News
Posted: August 16th, 2010, 2:33pm EDT by By NATASHA SINGER
Tags: [edit]
State insurance commissioners discuss the new health care law. An F.D.A. advisory panel is to review a new use for an antidepressant.
-
Glaxo Censures Sale of Supplements
Posted: August 13th, 2010, 2:52pm EDT by By NATASHA SINGER
Tags: [edit]
While Glaxo investigates a compound found in red wine as a potential cancer and diabetes drug, two employees were involved in a nonprofit group selling the substance as a dietary supplement.
NYT > Business
-
Produce by ‘Prescription’ Seeks to Address Childhood Obesity
Posted: August 13th, 2010, 1:23am EDT by By NATASHA SINGER
Tags: [edit]
Some doctors in Massachusetts are handing out coupons for use at farmers’ markets in an effort to promote healthy eating and combat childhood obesity.
NYT > Health
-
Produce by ‘Prescription’ Seeks to Address Childhood Obesity
Posted: August 13th, 2010, 1:23am EDT by By NATASHA SINGER
Tags: [edit]
Some doctors in Massachusetts are handing out coupons for use at farmers’ markets in an effort to promote healthy eating and combat childhood obesity.
-
Stroke Patients Discontinue Medications
Posted: August 9th, 2010, 5:51pm EDT by By NATASHA SINGER
Tags: [edit]
A multi-pronged approach is suggested to improve medication use among stroke patients.
-
This Week's Health Industry News
Posted: August 9th, 2010, 11:16am EDT by By NATASHA SINGER
Tags: [edit]
The House is scheduled to vote Tuesday on a bill that provides aid to states to prevent cuts to Medicaid.